Overview

THE INDIAN MARKET
A country of 1.06 billion people spanning a whole subcontinent, across 3,287,590 sq. km, 29 states and 6 union territories, speaking 15 different official languages, with myriad distinct cultures, and a heritage that goes back 5000 years, India is a country of diversity and depth like no other in the world.

This is Nitin’s Domestic Market
Our domestic product range spans Formulations across variour therapeutic segments: Antimalarials, Antiemetics, Antibiotics, Analgesics, Antiarthritics, Antidiabetics, Cardiac Care, Cough & Cold Therapy, Dermatology, and Neuropsychiatry segments. Nitn markets over 300 formulations in virtually every dosage form: tablets, capsules, oral liquids, dry powders for suspension, and injectables (liquid and dry).
Our finished formulations are available in over 40,000 retail shops, catered to by a network of over 300 distributors, 500 wholesalers, 150 marketing associates and marketing personnel service over 100,000 doctors across the country.
.

 
DOMESTIC DIVISIONS

PHARMA DIVISION
The oldest of Nitin’s divisions, handling the largest number of brands, this division manages our newer Cephalosporins, Antibacterials, Antimalarials, Non Steroidal Anti-Inflammatory Drugs (NSAIDs) and Cough preparations. Some of the other leading brands managed by this division are: Nitzole, Nitzole-D, Necob, Necob Plus, Nitaxim, Nefzon, Nitizest, N-Zol, Nicin, Neodec, Nandro, Nitipime, Nether, Niclospas. The pharma division handles 125 +products.
 

NEWSURGE.
Nitin’s second division, NEWSURGE marketing focus is on established Anti-Infectives, Antidiabetics, Antihipertensive, and mature brands of Nitin in the Antimalarial, Antiemetic & Antiinfective segment. This division has 61 products. Few of the leading brands are Nulofen, Nutaspas, Lifon, Xemel, Lewin, Lifon-T.
en_USEnglish